Daily funding roundup - January 8th, 2019

LendingFront raised $4M; Headset raised $12.1M; Managed by Q raised $25M; Humatics raised $28M

Carson Living: Carson is a real estate tech startup that provides services to unstaffed residential buildings. Carson has raised $3 million in seed funding led by BuildingLink, an online property management platform. Read more

LendingFront: LendingFront is a complete white-label small business lending/credit software platform for banks and other financial institutions. LendingFront has raised $4 million in Series A funding. Information Venture Partners led the round, with participation from Newark Venture Partners, Revel Partners,Contour Venture Partners, Struck Capital, ValueStream Ventures and Las Olas VC. Read more

Flytrex: Flytrex develops drone delivery systems that simplify deliveries & enhance efficiency by shortening delivery times & lowering overall costs. Flytrex has raised $7.5 million in Series B funding led by Benhamou Global Ventures. Read more

Scape Technologies: Scape is a computer vision startup, building the localization engine for city-scale augmented reality. Scape has raised $8 million in seed funding from LocalGlobe, Mosaic Ventures, Fly Ventures and Entrepreneur First. Read more

Headset: Headset is a data-driven tech company that provides business intelligence platform for the cannabis industry. Headset has raised $12.1 million in Series A funding co-led by Poseidon Asset Management and AFI Capital Partners. Read more

Keros Therapeutics: Keros Therapeutics is a drug startup that's developing therapies for neuromuscular diseases. Keros Therapeutics has raised $23 million in Series B funding from Global Health Sciences Fund and earlier investors Pontifax, Arkin BioVentures, Partners Innovation Fund and Medison Pharma. Read more

RainFocus: RainFocus creates software solutions to help event marketers understand events data, enhance sales, and marketing reach. RainFocus  has raised $40 million from the growth equity firm JMI Equity. Read more

Managed By Q: Managed by Q provides subscription and on-demand office services, from cleaning and maintenance to supply replenishment and wellness. Managed by Q has raised $25 million more to its Series C round led by earlier backers RRE and GV, with participation from new investors DivCo West,Oxford Properties and others. The fresh capital brings the total round to $55 million. Read more

Exscientia: Exscientia is applying AI and big data processing to accelerate drug discovery and development. Exscientia has raised $26 million in Series B funding from Celgene, GT Healthcare Capital Partners and earlier investor Evotec. Read more

Humatics: Humatics is developing microlocation products that will revolutionize how people and machines locate, navigate, and collaborate. Humatics has raised $28 million in Series A-1 funding led by Tenfore Holdings, with participation from Blackhorn Ventures, JCI Ventures, Fontinalis Partners, Airbus Ventures, Lockheed Martin Ventures and Presidio Ventures. Read more

Lambda School: Lambda School trains people to be software engineers for free in exchange for a share of future income. Lambda School has raised $30 million in Series B funding at a $150 million post-money valuation led byBedrock Capital, with participation from Vy Capital, GGV Capital, Google Ventures, Y Combinator and Sound Ventures. Read more

Stelexis: Stelexis Therapeutics is to become the leading cancer therapeutics company, through the discovery and development of novel drugs, utilizing its proprietary platform to selectively target pre-cancerous stem cells. Stelexis Therapeutics has raised $43 million in Series A funding led by Deerfield Management. Read more

Dorae: Dorae is a leading distributed ledger technology company for raw materials. Dorae  has raised $50 million in Series B funding from undisclosed investors, reports Axios. Read more

Cabaletta Bio: Cabaletta Bio is a biopharmaceutical company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases. Cabaletta Bio has raised $50 million in Series B funding. Investors include Deerfield Management Company,Boxer Capital of Tavistock Group, Redmile Group, Cormorant Capital, Adage Capital Management, and 5AM Ventures. Read more

BrightGene: BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. BrightGene has raised $80 million in later-stage funding led by Sequoia China and HighLight Capital, with participation from GF Qianhe Investment. Read more

Apollomics: Apollomics is an emerging life sciences oncology company focused on developing innovative medicines targeting the growth and proliferation of cancer cells for which available treatments are inadequate. Apollomics has raised $100 million in Series B funding. CMB International led the round, with participation from earlier backer OrbiMed Asia. Read more

If you are interested in being included in our funding roundup, submit your press release or blog post about your financing round to kristin@vator.tv. If you want a longer write-up, please do give us a couple days heads up. If you'd like to be included in our Today's Entrepreneur column, please send me your Vator profile.